Clinical Trials on Respiratory Abnormality in Belgium

Total 1978 results

Cliniques universitaires Saint-Luc- Université...

Unknown

Early Mobilization: Evaluation of Feasibility and Security in Pediatric Intensive Care Unit

Cardio-Respiratory Distress

Belgium
University Hospital, Ghent
XEOS Medical

Recruiting

Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study (ThorPET)

Lung Neoplasms | PET-CT Specimen Imager

Belgium
University of Liege
European Union

Completed

Effect of a Synbiotic "Probiotical®/Bactecal® " in Asthma

Asthma

Belgium
KU Leuven

Unknown

Monitoring and Telecoaching of Physical Activity in Patients With Stage III and IV Non-small Cell Lung Cancer

Neoplasms | Exercise

Belgium
Centre Hospitalier Universitaire Saint Pierre

Suspended

Influence of an Asthma Education Programme on Asthma Control During Pregnancy

Asthma

Belgium
Centre Hospitalier Universitaire Saint Pierre

Completed

Correlation Between Five Asthma Control Questionnaires

Asthma

Belgium
Wilfried De Backer
UCB Pharma

Completed

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Asthmatic Patients

Asthma

Belgium
University Ghent

Completed

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

Asthma

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Influence of Techniques of Chest Physiotherapy in the Pediatric Intensive Care

Atelectasis

Belgium
Osivax
Center for vaccinology (CEVAC), University of Ghent

Completed

Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.

Influenza

Belgium
Osivax
Centre for vaccinology (CEVAC), University of Ghent

Completed

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Influenza

Belgium
Osivax
Center for vaccinology (CEVAC), University of Ghent, Belgium

Completed

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

Influenza

Belgium
GlaxoSmithKline

Completed

Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population

Influenza

Belgium
Seqirus
Novartis Vaccines

Completed

Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

Influenza

Belgium
Visterra, Inc.

Completed

Influenza Challenge Study of VIS410 in Healthy Volunteers

Influenza

Belgium
Crucell Holland BV

Completed

Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

Influenza

Belgium
Novartis
Novartis Vaccines

Completed

A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age

Influenza

Belgium
European Lung Cancer Working Party
Jules Bordet Institute

Active, not recruiting

Has Inflammation a Significant Implication in Lung Cancer Evolution?

Lung Neoplasms

Belgium
Universitair Ziekenhuis Brussel

Unknown

Protein-energy Enriched Milk for Infants With Bronchiolitis (PEMIB)

Bronchiolitis

Belgium
Pierre Wauthy

Completed

Post-Surgical Mediastinitis Within the CHU Brugmann Hospital

Mediastinitis

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Unknown

Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas

Emergencies | Covid19 | Hypoxemic Respiratory Failure

Belgium
Cyril Barbezange
Sciensano; Belgian Federal Public Service, Food Chain Safety and Environment; Agentschap Zorg en Gezondheid

Enrolling by invitation

Zoonotic Influenza Surveillance in Belgium (ZOOIS)

Influenza, Human

Belgium
Osivax
Aepodia

Completed

Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects

Influenza

Belgium
GlaxoSmithKline

Completed

Revaccination With Influenza Vaccine GSK1247446A

Influenza | Influenza, Human

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years

Influenza

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults

Influenza

Belgium
Universiteit Antwerpen
Yakult Honsha Co., LTD

Completed

Study of the Effect of Probiotics on Respiratory Morbidity After Influenza Vaccination of Elderly in Nursing Homes

Respiratory Tract Infections

Belgium
Onze Lieve Vrouw Hospital

Completed

Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade (REDNESII)

Respiratory Muscles | Electromyography

Belgium
Université Catholique de Louvain

Recruiting

Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units (Pop-PK/PD)

Pharmacokinetics | Infection | Infection, Bacterial | Anti-Bacterial Agents | Drug Monitoring | Infections, Respiratory

Belgium
University Hospital, Antwerp
Philips Respironics

Terminated

Cough Assist in Bronchiolitis

Bronchiolitis | Respiratory Syncytial Virus

Belgium
LiteVax BV
University Hospital, Ghent

Completed

Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin (TETRALITE-I)

Influenza

Belgium
Vaccitech (UK) Limited

Completed

Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly

Influenza

Belgium
GlaxoSmithKline

Completed

Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults

Influenza

Belgium
Onze Lieve Vrouw Hospital
Universiteit Antwerpen; MSD Belgium BVBA

Completed

Functional Respiratory Imaging After Neostigmine or Sugammadex (FRINeoS)

Respiratory-Gated Imaging Techniques

Belgium
Centre Hospitalier Universitaire Saint Pierre

Terminated

Impact of Reduction of Dust Mite Allergenic Load on Step Down of Inhaled Corticosteroids in Stable Asthma

Asthma

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven; Research Foundation Flanders

Unknown

The Effect of Odors on Asthma Symptoms

Asthma

Belgium
Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above

Human Influenza

Belgium
Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above

Human Influenza

Belgium
Immune Targeting Systems Ltd

Completed

Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers

Influenza A

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Endobronchial Valves in Persistent Air Leak

Malignant Neoplasm of Lung

Belgium

3

Subscribe